Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease.


Journal

NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863

Informations de publication

Date de publication:
22 Apr 2021
Historique:
received: 22 11 2020
accepted: 23 03 2021
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 24 4 2021
Statut: epublish

Résumé

Highly pathogenic emm1 Streptococcus pyogenes strains secrete the multidomain Streptococcal inhibitor of complement (SIC) that binds and inactivates components of the innate immune response. We aimed to determine if naturally occurring or vaccine-induced antibodies to SIC are protective against invasive S. pyogenes infection. Immunisation with full-length SIC protected mice against systemic bacterial dissemination following intranasal or intramuscular infection with emm1 S. pyogenes. Vaccine-induced rabbit anti-SIC antibodies, but not naturally occurring human anti-SIC antibodies, enhanced bacterial clearance in an ex vivo whole-blood assay. SIC vaccination of both mice and rabbits resulted in antibody recognition of all domains of SIC, whereas naturally occurring human anti-SIC antibodies recognised the proline-rich region of SIC only. We, therefore, propose a model whereby natural infection with S. pyogenes generates non-protective antibodies against the proline-rich region of SIC, while vaccination with full-length SIC permits the development of protective antibodies against all SIC domains.

Identifiants

pubmed: 33888727
doi: 10.1038/s41541-021-00326-3
pii: 10.1038/s41541-021-00326-3
pmc: PMC8062509
doi:

Types de publication

Journal Article

Langues

eng

Pagination

62

Subventions

Organisme : Wellcome Trust (Wellcome)
ID : WT099079MA
Organisme : Wellcome Trust (Wellcome)
ID : WT099079MA
Organisme : DH | National Institute for Health Research (NIHR)
ID : Imperial Biomedical Research Centre
Organisme : DH | National Institute for Health Research (NIHR)
ID : Imperial BRC
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 7480
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 7480

Références

Infect Immun. 2005 Aug;73(8):4723-31
pubmed: 16040985
J Clin Microbiol. 2008 Jul;46(7):2359-67
pubmed: 18463210
J Infect Dis. 2003 Sep 15;188(6):818-27
pubmed: 12964112
PLoS Pathog. 2006 Jan;2(1):e5
pubmed: 16446783
J Biol Chem. 2011 Jan 14;286(2):1331-40
pubmed: 21068386
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3128-33
pubmed: 9501227
J Clin Microbiol. 2013 Jul;51(7):2089-95
pubmed: 23616448
Autoimmun Rev. 2008 Jun;7(6):435-9
pubmed: 18558358
J Biol Chem. 2003 May 9;278(19):16561-6
pubmed: 12621031
J Infect Dis. 2001 Feb 15;183(4):633-9
pubmed: 11170990
J Med Microbiol. 2002 Jul;51(7):589-650
pubmed: 12132776
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7646-51
pubmed: 12032337
J Biol Chem. 1996 Jan 12;271(2):1081-8
pubmed: 8557634
Sci Rep. 2015 Oct 28;5:15825
pubmed: 26508447
Sci Rep. 2018 Apr 13;8(1):5950
pubmed: 29654237
J Clin Microbiol. 2009 Apr;47(4):1155-65
pubmed: 19158266
Immunology. 2004 Apr;111(4):444-52
pubmed: 15056382
Front Immunol. 2018 Feb 22;9:236
pubmed: 29520265
Immunology. 2001 Jul;103(3):390-8
pubmed: 11454069
J Biol Chem. 2005 May 20;280(20):20120-5
pubmed: 15769742
J Innate Immun. 2010;2(6):587-95
pubmed: 20814187
Mol Microbiol. 2010 Jun;76(6):1387-97
pubmed: 20158613
Clin Infect Dis. 2012 Aug;55(4):479-87
pubmed: 22534148
J Exp Med. 1959 Aug 1;110(2):271-92
pubmed: 13673139
J Infect Dis. 2000 Nov;182(5):1425-36
pubmed: 11015234
Emerg Infect Dis. 1999 Mar-Apr;5(2):254-63
pubmed: 10221878
Nat Med. 1999 Aug;5(8):924-9
pubmed: 10426317
J Infect. 2016 Apr;72(4):450-9
pubmed: 26880087
Infect Immun. 2002 Sep;70(9):4908-16
pubmed: 12183536

Auteurs

Lionel K K Tan (LKK)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.

Mark Reglinski (M)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
School of Life Sciences, University of Dundee, Dundee, UK.

Daryl Teo (D)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.

Nada Reza (N)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.

Lucy E M Lamb (LEM)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, UK.

Vaitehi Nageshwaran (V)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.

Claire E Turner (CE)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
The Florey Institute, University of Sheffield, Sheffield, UK.

Mats Wikstrom (M)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Amgen Inc, Attribute Sciences, Thousand Oaks, CA, USA.

Inga-Maria Frick (IM)

Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden.

Lars Bjorck (L)

Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden.

Shiranee Sriskandan (S)

Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK. s.sriskandan@imperial.ac.uk.

Classifications MeSH